Smith & Nephew spend $1.7bn on well-timed ArthroCare buy (Evaluate Group)
Smith & Nephew's $1.7bn cash purchase of a sports medicine specialist, ArthroCare, means that the orthopaedics giant has made good on its promise to diversify into high-growth areas.
The UK firm says that ArthroCare’s radiofrequency-based surgical technology will mesh with its range of mechanical saws and enable it to treat patients’ shoulders as well as strengthening its knee repair business. The ortho market is enjoying a remarkable resurgence at the moment on the back of improving overall employment rates, tha...
The Orthopedics Industry 
